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A quantitative microinjection procedure has been developed to demonstrate muscle-specific transcription of the myosin 
light chain Z-A (MLCZ-A) promoter in differentiated chicken primary breast muscle cells. Nuclear protein binds to the 
distal region of the required promoter sequence but not to a mutated version of this sequence. The functional signiticance 
of this specific DNA-protein interaction for the promoter activity is demonstrated by ‘in vivo’ competition of microin- 
jetted MLC-CAT reporter construct together with excess of synthetic oligonucleotides encompassing the protein binding 
sites. 
Muscle-specific gene expression; Nuclear protein; Binding competition 
1. INTRODUCTION 
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model system for studying tissue-specific gene 
regulation since the morphological transition fram 
myoblastir precursor cells to differentiated, 
multinucleated myotubes is accompanied by the 
accumulation of newly synthesized contractile pro- 
teins and their corresponding mRNAs [ 1,2]. The 
vast increase of muscle-specific mRNAs is primari- 
ly controlled at the level of transcription [3]. 
Heterokaryon experiments have elegantly demon- 
strated the involvement of diffusable, trans- 
activating factors in the regulation of muscle gene 
expression [4]. Understanding the mechanisms 
which determine the cell-specific activation of 
muscle gene promoters requires therefore the 
elucidation of interactions of cellular factors with 
gene sequences governing cell type-specific expres- 
sion. Binding properties of trans-acting factors 
have been determined in numerous instances 
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(review [5]). Only a few studies, however, have 
demonstrated the functional relevance of these in- 
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assays [6]. We here demonstrate by nuclear 
microinjection that a fragment of the chicken car- 
diac myosin light chain 2-A promoter extending 
from nucleotides - 135 to + 25 is sufficient to con- 
fer myotube-specific expression. We furthermore 
show that the distal sequence of this fragment 
specifically binds to nuclear factors. The func- 
tional significance of this factor-DNA interaction 
is illustrated by in vivo competition with protein- 
binding oligonucleotides which leads to the effec- 
tive inhibition of the MLC2-A promoter activity in 
the expressing cells. 
2. EXPERIMENTAL 
Hybrid genes containing promoter fragments of the chicken 
MLC2-A gene were fused to the bacteria1 chloramphenicol 
acetyltransferase (CAT) gene as described [7]. 
Primary cells for transfection or microinjection experiments 
were isolated from 12.day embryonic chicken pectoralis muscle 
(8( and cultured UC calkgen-coated caves ~8~s. For each 
nuclear injection experiment 50 nuclei of primary myoblasts 
(Mb) or myotubes (Mt) were microinjected with equal volumes 
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(approx. 10 fl) of CAT expressing reporter plasmid (1 mg/ml) 
[9, lo] plus competing oligonucleotides. CAT activity was deter- 
mined as in [lO,ll]. For gel mobility-shift assays, radiolabeled 
MLCZ-A promoter fragment (- 135/+25) or the synthetic 
oligonucleotide DPE was incubated with various concentrations 
of nuclear extracts prepared from 12-day embryonic chicken 
hearts according to [12]. Poly dI/dC (80pgIml) and salmon 
sperm DNA (6 /g/ml) were included as unspecific carrier. The 
assay was performed as described [13]. 
-competitor DNA +competitor DNA 
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3. RESULTS 
We have previously shown that the chicken 
MLC2-A gene promoter linked to the bacterial 
CAT reporter gene is transcriptionally active when 
transfected into chicken primary breast and car- 
diac muscle cells but inactive in primary skin 
fibroblasts and several myogenic murine cell lines 
[7]. Although this earlier observation established 
the fact that the MLC2-A promoter exhibits mus- 
cle specificity, it did not formally distinguish 
whether transcription was activated in myoblasts 
or in fused myotubes. In primary muscle cultures 
differentiation proceeds spontaneously during the 
culturing period, hence both types of myogenic 
cells are always present. We therefore devised a 
transient expression assay in which MLC2-CAT 
chimeras were directly microinjected into nuclei of 
either unfused, mononucleated myoblasts or into 
62% 0,5% 
Mt. Mb. Mt. Mb. Fb. 
Fig. 1. Myotube-specific expression of the chicken MLC2-A 
promoter fragment of plasmid LC-pUC-CAT (- 135/ + 25) [7] 
linked to the CAT reporter gene. The percentage of 
chloramphenicol conversion is indicated. Two independent 
injection experiments are shown. Mb, myoblasts; Mt, 
myotubes; Fb, fibroblasts. 
1 23456789 
Fig.2. Gel mobility-shift assays with the MLC2-A promoter 
fragment (- 135/+ 25). Radiolabelled DNA was incubated with 
the indicated amounts of protein in nuclear extracts (lanes l-5). 
A 20-fold molar excess of the same unlabelled fragment was 
used as specific competitor DNA (lanes 6-9). 
nuclei of fully differentiated, multinucleated 
myotubes. By this approach, the promoter activity 
could be determined through the CAT activity in 
groups of cells, which had been selected for 
microinjection according to their morphology. As 
illustrated in fig.1 for two independent ex- 
periments, transcriptional activity of the 160 bp 
promoter fragment (- 135/ + 25) of the MLC2-A 
gene was approx. lOO-fold higher in differentiated 
myotubes than in mononucleated myoblasts. This 
result indicated that differentiation of muscle cells 
was required for maximal promoter activity. A 
slightly higher activity was observed in myoblasts 
than in fibroblasts which is most probably due to 
the fact that some of the injected muscle precursor 
cells had already been postmitotic, although they 
had not yet been fused to multinucleated fibers. 
To elucidate the interaction of the MLC2-A pro- 
moter region with nuclear proteins, gel mobility- 
shift assays were performed [ 131. The 160 bp 5’ 
upstream DNA fragment of the MLC2-A gene 
(- 135/ + 25) formed a slowly migrating complex 
when incubated with increasing concentrations of 
nuclear extracts from chicken embryonic heart 
muscle (fig.2, lanes l-5). This complex formation 
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Fig.3. Demonstration of protein binding to the distal promoter element (DPE). (a) The reporter fragment from LCA-64 or DPE 
oligonucleotides were used as radiolabelled probes (lanes 1-8 and 9, respectively). The competing fragments were added at the 
indicated molar excess over probe. (b) Competition of protein binding to DPE (lanes 1.6) by the addition of an 8-8000-fold molar 
excess of unlabelled DPE (lanes 2-5) and Mm 1 oligonucleotides (lanes 7- 10). Both competing oligonucleotides were double stranded. 
The sequences of DPE and Mutl are shown in fig.4. 
was specifically prevented when unlabelled 160 bp 
DNA fragment was added in excess as competitor 
(fig.2, lanes 6-9). A more detailed localization of 
the protein-binding site was obtained from a gel 
retardation assay using the 89 bp promoter frag- 
ment of the smaller, yet transcriptionally active 
deletion, LCA-64 [7]. As illustrated in fig.3a, pro- 
tein binding was completely inhibited by a 
40-lOO-fold excess of unlabelled reporter frag- 
ment (- 64/ + 25). In contrast, the shorter 5 ’ dele- 
tion fragment (- 39/+25), derived from the 
transcriptionally inactive deletion LCA-39 [7] 
failed to compete for complex formation, even at 
go-fold molar excess. From this result it was in- 
ferred that the 5 ’ distal segment of the promoter 
contains an essential protein-binding site. Indeed, 
a synthetic oligonucleotide of this distal promoter 
element (DPE) formed a specific protein complex 
when incubated with nuclear extracts (fig.3a, lane 
9). Footprinting analysis of this DNA region with 
DNaseI and ExoIII reveals protection of protein- 
binding sites from nucleotides -61 to - 57 and 
from - 54 to - 42 (in preparation). The specificity 
of the protein binding was demonstrated when 
unlabelled DPE at concentrations between 8- and 
8000-fold molar excess over the labelled probe 
were shown to inhibit effectively the complex for- 
mation (fig.3b). In contrast, a mutated 
oligonucleotide version (Mut l), which contains a 
sequence that has been altered at 5 nucleotide posi- 
tions did not compete, suggesting that the protein- 
binding capacity is sequence specific and involves 
some or all of the 5 bases that had been mutated 
(fig.3b). 
The attempt to assess the functional importance 
of the DPE forming a protein complex by in vivo 
competition experiments was unsuccessful in our 
hands with DNA transfection techniques. Similar 
observations have been reported by others for dif- 
ferentiated C2C12 muscle cells [14]. We therefore 
decided to inject directly the reporter construct 
LCA-64 together with synthetic double-stranded 
DPE oligonucleotide as competitor into nuclei of 
myotubes. As illustrated in fig.4, microinjected in- 
dicator construct LCA-64 alone was highly active 
(lane 1). Coinjection of increasing concentrations 
of competing DPE oligonucleotide, however, led 
to a gradual and significant reduction of the 
MLC2-A promoter activity (lanes 2-5). When the 
mutated oligonucleotide Mutl was coinjected at 
similar molar concentrations, control levels of 
CAT reporter gene expression were obtained. 
These results indicated that the distal promoter ele- 
ment (DPE) which is able to bind to nuclear fac- 
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REPORTER: LCA - 6'4 
DPE: TGGACATGGGGTTATTTTTAGCCTGG 
MUT 1: TGGACATGGGCTGAATTGTACCCTGG 
Fig.4. In viva competition of the transcription of microinjected 
reporter plasmid LCA-64 (sequence shown in fig.3a). Double- 
stranded DPE (lanes 2-Q and ds-Mm1 (lanes 6-8) were 
coinjected at the indicated concentrations. The altered bases in 
Mutl are underlined. 
tots is also functionally required for the 
transcription of the MLC2-A promoter. 
4. DISCUSSION 
The aim of this investigation was to demonstrate 
in vivo the critical interaction of a cis-acting pro- 
moter element (DPE) of the muscle-specific 
myosin light chain 2 gene with positively trans- 
acting nuclear factor(s). To this end, we have ex- 
amined the binding properties of an essential 5’ 
upstream promoter segment, and more important- 
ly, established a procedure by which its functional 
involvement for transcriptional activation could be 
demonstrated. The combination of the quan- 
titative transient CAT expression assay and 
microinjection of reporter DNA plasmids together 
with competing oligonucleotides into nuclei of dif- 
ferentiated muscle cells yielded quantitative and 
reproducible results. From these in vivo competi- 
tion studies it can be concluded that a sequence 
located in the DPE of the MLC promoter not only 
binds nuclear components of the muscle cell in a 
rate-limiting and concentration-dependent fashion 
but also that this interaction is an essential require- 
ment for the transcriptional activity in living cells. 
Most significantly, the in vivo competition of this 
transcriptional activity could not be achieved with 
a mutated oligonucleotide that also did not bind to 
nuclear proteins in vitro. These results unam- 
biguously demonstrate the requirement of 
sequence-specific trans-acting factor(s) for the 
transcription in an in vivo situation. The method 
of microinjecting synthetic oligonucleotides in 
single cell nuclei to compete for limiting protein 
factors involved in transcriptional activation 
should allow the determination of various cis- and 
trans-acting components, even in mixed cell 
populations of various differentiated cell types. 
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